BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 30070329)

  • 1. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
    Yue C; Ren Y; Ge H; Yan L; Xu Y; Wang G; Wu J
    J Cell Physiol; 2019 Dec; 234(12):23685-23694. PubMed ID: 31169303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DUXAP10 promotes the proliferation, migration, and inhibits apoptosis of prostate cancer cells.
    Wang XF; Chen J; Gong YB; Qin YC; Wang L; Li NC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3699-3708. PubMed ID: 31114994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21.
    Wang Z; Ren B; Huang J; Yin R; Jiang F; Zhang Q
    Cancer Biol Ther; 2018; 19(11):998-1005. PubMed ID: 30215547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.
    Tian S; Tang M; Li J; Wang C; Liu W
    Aging (Albany NY); 2020 Dec; 13(2):2459-2479. PubMed ID: 33318305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
    Yue C; Liang C; Ge H; Yan L; Xu Y; Li G; Li P; Wei Z; Wu J
    Onco Targets Ther; 2019; 12():4555-4566. PubMed ID: 31354289
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA-494-3p protects rat cardiomyocytes against septic shock via PTEN.
    Wu P; Kong L; Li J
    Exp Ther Med; 2019 Mar; 17(3):1706-1716. PubMed ID: 30783439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol.
    Miyata S; Fukuda Y; Tojima H; Matsuzaki K; Kitanaka S; Sawada H
    Leuk Res; 2015 Sep; 39(9):927-32. PubMed ID: 26194899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer.
    Zhao J; Xu L; Dong Z; Zhang Y; Cao J; Yao J; Xing J
    Front Cell Dev Biol; 2022; 10():832388. PubMed ID: 35186937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUXAP10 regulates proliferation and apoptosis of chronic myeloid leukemia via PTEN pathway.
    Yao R; Feng WT; Xu LJ; Zhong XM; Liu H; Sun Y; Zhou LL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4934-4940. PubMed ID: 30070329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
    Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
    Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
    Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INNO-406 inhibits the growth of chronic myeloid leukemia and promotes its apoptosis via targeting PTEN.
    Sun J; Wang Y; Sun L
    Hum Cell; 2020 Oct; 33(4):1112-1119. PubMed ID: 32862368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.
    Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K
    Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.